The impact of recent screening recommendations on prostate cancer screening in a large health care system

Journal of Urology

Volumn 191, Issue 6, 2014, Pages 1737-1742

  Aslani, Afshin ^a   Minnillo, Brian J ^a   Johnson, Ben ^a   Cherullo, Edward E ^a   Ponsky, Lee E ^a   Abouassaly, Robert ^a  

^a CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

mass screening; practice guidelines as topic; prostate; prostate specific antigen; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; CHOLESTEROL;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER SCREENING; FAMILY MEDICINE; GENERAL PRACTITIONER; HEALTH CARE SYSTEM; HEMATOLOGY; HUMAN; INTERNAL MEDICINE; MAJOR CLINICAL STUDY; MEDICAL SOCIETY; ONCOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROSTATE CANCER; RETROSPECTIVE STUDY; RURAL AREA; SECONDARY ANALYSIS; SUBURBAN AREA; TREND STUDY; UNITED STATES; UNIVERSITY HOSPITAL; URBAN AREA; UROLOGIST; UROLOGY; CLINICAL TRIAL; EARLY DIAGNOSIS; FOLLOW UP; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; MULTICENTER STUDY; PRIMARY HEALTH CARE; PROGNOSIS; PROSTATIC NEOPLASMS; STANDARDS; TRENDS; CHOLESTEROL BLOOD LEVEL; MEDICAL SPECIALIST;

EARLY DETECTION OF CANCER; FOLLOW-UP STUDIES; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; MORBIDITY; PRACTICE GUIDELINES AS TOPIC; PRIMARY HEALTH CARE; PROGNOSIS; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; UNITED STATES;

EID: 84900459205     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2013.12.010     Document Type: Article

References (27)

1. D.L. Hoyert, and J. Xu Deaths: preliminary data for 2011 Natl Vital Stat Rep 61 2012 1
2. O.W. Brawley Prostate cancer epidemiology in the United States World J Urol 30 2012 195
3. National Cancer Institute; Prostate-Specific Antigen (PSA) Test. Available at http://www.cancer.gov/cancertopics/factsheet/detection/PSA. Accessed July 2012.
4. A.L. Potosky, B.A. Miller, and P.C. Albertsen et al. The role of increasing detection in the rising incidence of prostate cancer JAMA 273 1995 548
5. S.J. Jacobsen, S.K. Katusic, and E.J. Bergstralh et al. Incidence of prostate cancer diagnosis in the eras before and after serum prostate-specific antigen testing JAMA 274 1995 1445
6. L. Klotz Active surveillance for favorable-risk prostate cancer: what are the results and how safe is it? Curr Urol Rep 8 2007 341
7. R. Etzioni, J.M. Legler, and E.J. Feuer et al. Cancer surveillance series: interpreting trends in prostate cancer - part III: quantifying the link between population prostate-specific antigen testing and recent declines in prostate cancer mortality J Natl Cancer Inst 91 1999 1033
8. UK National Screening Committee Policy Database: The UK NSC Policy on Prostate Cancer Screening/PSA Testing in Men over the Age of 50. Available at http://screening.nhs.uk/prostatecancer. Accessed December 2010.
9. G.L. Andriole, E.D. Crawford, and R.L. Grubb et al. Mortality results from a randomized prostate-cancer screening trial N Engl J Med 360 2009 1310
10. F.H. Schröder, J. Hugosson, and M.J. Roobol et al. Screening and prostate-cancer mortality in a randomized European study N Engl J Med 360 2009 1320
11. V.A. Moyer Screening for prostate cancer: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 157 2012 120
12. D. Ilic, M.M. Neuberger, and M. Djulbegovic et al. Screening for prostate cancer Cochrane Database Syst Rev 1 2013 CD004720
13. A.J. Martin, S.J. Lord, and H.E. Verry et al. Risk assessment to guide prostate cancer screening decisions: a cost-effectiveness analysis Med J Aust 198 2013 546
14. K.L. Greene, P.C. Albertsen, and R.J. Babayian et al. Prostate specific antigen best practice statement: 2009 update J Urol 189 suppl. 2013 S2
15. K.L. Greene, P.C. Albertsen, and R.J. Babaian et al. Prostate specific antigen best practice statement: 2009 update J Urol 182 2009 2232
16. M.F. McNaughton-Collins, and M.J. Barry One man at a time - resolving the PSA controversy N Engl J Med 365 2011 1951
17. L.G. Gomella, X.S. Liu, and E.J. Trabulsi et al. Screening for prostate cancer: the current evidence and guidelines controversy Can J Urol 18 2011 5875
18. A. Qaseem, M.J. Barry, and T.D. Denberg et al. Screening for prostate cancer: a guidance statement from the Clinical Guidelines Committee of the American College of Physicians. Clinical Guidelines Committee of American College of Physicians Ann Intern Med 158 2013 761
19. H.B. Carter, P.C. Albertsen, and M.J. Barry et al. Early Detection of Prostate Cancer: AUA Guideline 2013 American Urological Association Linthicum
20. Poage WL: Impact of the controversy over prostate cancer screening on the participation in a national, free, screening program between 2008 and 2011. Presented at annual meeting of American Public Health Association, San Francisco, California, October 30, 2012; abstract 267022.
21. J.S. Ross, R. Wang, and J.B. Long et al. Impact of the 2008 USPTF recommendation to discontinue prostate cancer screening among male Medicare beneficiaries Arch Intern Med 172 2012 1601
22. J.A. Cohn, C.E. Wang, and J.C. Lakeman et al. Primary care physician PSA screening practices before and after the final U.S. Preventive Services Task Force recommendation Urol Oncol 32 2014 41.e23
23. S.B. Zeliadt, R.M. Hoffman, and R. Etzioni et al. Influence of publication of US and European prostate cancer screening trials on PSA testing practices J Natl Cancer Inst 103 2011 520
24. D. Howard, F. Tangka, and G. Guy et al. Prostate cancer screening in men ages 75 and older fell by 8 percentage points after Task Force recommendation Health Aff (Millwood) 32 2013 596
25. J.S. Goodwin, A. Tan, and E. Jaramillo et al. Prostate-specific antigen testing in men aged 40-64 years: impact of publication of clinical trials J Natl Cancer Inst 105 2013 743
26. T. Nordström, M. Aly, and M.S. Clements et al. Prostate-specific antigen (PSA) testing is prevalent and increasing in Stockholm County, Sweden, despite no recommendations for PSA screening: results from a population-based study, 2003-2011 Eur Urol 63 2013 419
27. R. Evans, A. Edwards, and J. Brett et al. Reduction in uptake of PSA tests following decision aids: systemic review of current aids and their evaluations Patient Educ Couns 58 2005 13